Terms ending in 2030
Every in-force patent on Shire LLC's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,518,877 | Method and Product for Treatment And/Or Prevention of Complications of Prematurity In force · High confidence | Shire Human Genetic Therapies, Inc. | In force | High confidence | |
| US 9,187,525 | Methods of Treating Ophthalmic Diseases Using Npr-B Agonists In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,778,622 | Enzymatic Activity-Based Detection In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,383,359 | Enzymatic Activity Based-Detection In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 8,980,327 | Capsule and Powder Formulations Containing Lanthanum Compounds In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,023,397 | Capsule and Powder Formulations Containing Lanthanum Compounds In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 8,371,092 | Apparatus and Methods for Reducing Capsule Elongation In force · High confidence | Shire Viropharma LLC | In force | High confidence | |
| US 10,576,166 | Liver Specific Delivery of Messenger RNA In force · Medium confidence | Translate Bio, Inc. | In force | Medium confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Shire LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.